Celldex Therapeutics Inc.

Ticker CLDX

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Hampton, New Jersey

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators…More

Visit website

Social Media Links

REPORT RATINGS

3.0 / 5.0 (3)

Celldex Therapeutics Inc. reports have an aggregate usefulness score of 3.0 based on 3 reviews.

Celldex Therapeutics Inc.

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Celldex Therapeutics Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.